Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Correction: Vaccination of Mice Using the West Nile Virus E-Protein in a DNA Prime-Protein Boost Strategy Stimulates Cell-Mediated Immunity and Protects Mice against a Lethal Challenge

  • The PLOS ONE Staff

Correction: Vaccination of Mice Using the West Nile Virus E-Protein in a DNA Prime-Protein Boost Strategy Stimulates Cell-Mediated Immunity and Protects Mice against a Lethal Challenge

  • The PLOS ONE Staff
PLOS
x

The last sentence of the “WNV DNA Vaccine, Control Plasmid and E-protein” section of the Materials and Methods should read: “For protein booster vaccine formulation the E-protein was adjuvanted with 10 μg Matrix-M1 adjuvant (Novavax AB, Uppsala, Sweden).”

In addition, the following sentence should be inserted as the last sentence of the “Vaccination Procedures” section of the Materials and Methods: “Mice were boosted four weeks later either via an IM injection of the same does of WNV-DermaVir nanoparticles or via subcutaneous (s.c.) injection of recombinant E-protein ([28]) formulated with Matrix-M1 (a kind gift from Novavax AB, Uppsala, Sweden).”

Reference

  1. 1. De Filette M, Soehle S, Ulbert S, Richner J, Diamond MS, et al. (2014) Vaccination of Mice Using the West Nile Virus E-Protein in a DNA Prime-Protein Boost Strategy Stimulates Cell-Mediated Immunity and Protects Mice against a Lethal Challenge. PLoS ONE 9(2): e87837